Literature DB >> 20512434

Nano-coating of beta-galactosidase onto the surface of lactose by using an ultrasound-assisted technique.

Natalja Genina1, Heikki Räikkönen, Jyrki Heinämäki, Peep Veski, Jouko Yliruusi.   

Abstract

We nano-coated powdered lactose particles with the enzyme beta-galactosidase using an ultrasound-assisted technique. Atomization of the enzyme solution did not change its activity. The amount of surface-attached beta-galactosidase was measured through its enzymatic reaction product D-galactose using a standardized method. A near-linear increase was obtained in the thickness of the enzyme coat as the treatment proceeded. Interestingly, lactose, which is a substrate for beta-galactosidase, did not undergo enzymatic degradation during processing and remained unchanged for at least 1 month. Stability of protein-coated lactose was due to the absence of water within the powder, as it was dry after the treatment procedure. In conclusion, we were able to attach the polypeptide to the core particles and determine precisely the coating efficiency of the surface-treated powder using a simple approach.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20512434      PMCID: PMC2902327          DOI: 10.1208/s12249-010-9462-4

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  22 in total

1.  Protein inhalation powders: spray drying vs spray freeze drying.

Authors:  Y F Maa; P A Nguyen; T Sweeney; S J Shire; C C Hsu
Journal:  Pharm Res       Date:  1999-02       Impact factor: 4.200

Review 2.  Novel alternative methods for the delivery of drugs for the treatment of asthma.

Authors:  Hak Kim Chan; Nora Y K Chew
Journal:  Adv Drug Deliv Rev       Date:  2003-07-18       Impact factor: 15.470

3.  Spray-coating for biopharmaceutical powder formulations: beyond the conventional scale and its application.

Authors:  Yuh-Fun Maa; Mahmoud Ameri; Robert Rigney; Lendon G Payne; Dexiang Chen
Journal:  Pharm Res       Date:  2004-03       Impact factor: 4.200

Review 4.  Rational design of stable lyophilized protein formulations: some practical advice.

Authors:  J F Carpenter; M J Pikal; B S Chang; T W Randolph
Journal:  Pharm Res       Date:  1997-08       Impact factor: 4.200

5.  Spray-drying of air-liquid interface sensitive recombinant human growth hormone.

Authors:  Y F Maa; P A Nguyen; S W Hsu
Journal:  J Pharm Sci       Date:  1998-02       Impact factor: 3.534

6.  Aggregates formed during storage of beta-galactosidase in solution and in the freeze-dried state.

Authors:  S Yoshioka; Y Aso; K Izutsu; T Terao
Journal:  Pharm Res       Date:  1993-05       Impact factor: 4.200

7.  A new powder design method to improve inhalation efficiency of pranlukast hydrate dry powder aerosols by surface modification with hydroxypropylmethylcellulose phthalate nanospheres.

Authors:  Y Kawashima; T Serigano; T Hino; H Yamamoto; H Takeuchi
Journal:  Pharm Res       Date:  1998-11       Impact factor: 4.200

8.  Formulation of enterosoluble microparticles for an acid labile protein.

Authors:  Ahmed Kashif Alavi; Emilio Squillante; Ketan A Mehta
Journal:  J Pharm Pharm Sci       Date:  2002 Sep-Dec       Impact factor: 2.327

9.  The effect of process and formulation variables on the properties of spray-dried beta-galactosidase.

Authors:  J Broadhead; S K Rouan; I Hau; C T Rhodes
Journal:  J Pharm Pharmacol       Date:  1994-06       Impact factor: 3.765

10.  Compression behaviour of the enzyme beta-galactosidase and its mixture with microcrystalline cellulose.

Authors:  Tanja Kuny; Hans Leuenberger
Journal:  Int J Pharm       Date:  2003-07-09       Impact factor: 5.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.